Ge Health Care Technologies Inc. GEHC
We take great care to ensure that the data presented and summarized in this overview for GE HealthCare Technologies Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GEHC
Top Purchases
Top Sells
About GEHC
Insider Transactions at GEHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2024
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,998
-12.51%
|
$701,844
$78.0 P/Share
|
|
May 28
2024
|
Taha Kass Hout Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,300
-4.67%
|
$257,400
$78.7 P/Share
|
|
May 21
2024
|
Rodney F Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,965
+20.02%
|
-
|
|
May 21
2024
|
Lloyd Howell Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
Risa J Lavizzo Mourey Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+25.67%
|
-
|
|
May 21
2024
|
Catherine A Lesjak Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
Anne T Madden Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,965
+20.02%
|
-
|
|
May 21
2024
|
Tomislav Mihaljevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
William J Stromberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,209
+20.42%
|
-
|
|
May 21
2024
|
Watkin Phoebe L. Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
H Lawrence Culp Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+0.39%
|
-
|
|
May 15
2024
|
Jan Makela CEO, Imaging |
SELL
Open market or private sale
|
Direct |
66,955
-51.38%
|
$5,423,355
$81.54 P/Share
|
|
May 15
2024
|
Jan Makela CEO, Imaging |
BUY
Exercise of conversion of derivative security
|
Direct |
66,955
+17.16%
|
$4,753,805
$71.73 P/Share
|
|
May 13
2024
|
Jan Makela CEO, Imaging |
SELL
Open market or private sale
|
Direct |
20,227
-24.2%
|
$1,638,387
$81.57 P/Share
|
|
May 13
2024
|
Jan Makela CEO, Imaging |
BUY
Exercise of conversion of derivative security
|
Direct |
20,227
+19.49%
|
$1,274,301
$63.51 P/Share
|
|
May 01
2024
|
Frank R Jimenez GC & Corporate Secretary |
BUY
Open market or private purchase
|
Direct |
1,315
+1.71%
|
$99,940
$76.52 P/Share
|
|
Apr 01
2024
|
Roland Rott CEO, Ultrasound |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-3.39%
|
$75,330
$90.91 P/Share
|
|
Mar 15
2024
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
14,000,000
-30.02%
|
-
|
|
Mar 01
2024
|
Roland Rott CEO, Ultrasound |
BUY
Grant, award, or other acquisition
|
Direct |
4,179
+14.49%
|
-
|
|
Mar 01
2024
|
Roland Rott CEO, Ultrasound |
SELL
Payment of exercise price or tax liability
|
Direct |
4,555
-6.44%
|
$414,505
$91.28 P/Share
|
Last 12 Months Summary
Buy / Acquisition
219K
Shares
From
22
Insiders
| Grant, award, or other acquisition | 117K shares |
|---|---|
| Open market or private purchase | 1.32K shares |
| Exercise of conversion of derivative security | 100K shares |
Sell / Disposition
57.9M
Shares
From
17
Insiders
| Payment of exercise price or tax liability | 133K shares |
|---|---|
| Other acquisition or disposition | 57.7M shares |
| Open market or private sale | 109K shares |